Aronora Inc.

Portland, OR

UEI
K57JWU3XKX95
CAGE
6WCC6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1818 SW 4th Ave, Portland, OR 97201, USA
Website
aronora.com
Industry
  1. Information Technology
  2. Software & Services
  3. Internet Software & Services
SIC code
48 Communications
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Aronora Inc.

Aronora Inc. is a Portland, Oregon-based biotechnology company registered in the System for Award Management (SAM) since 2013, focusing on developing innovative pharmaceutical interventions for complex medical conditions. As a for-profit corporate entity, the company specializes in creating novel therapeutic agents targeting specific molecular pathways in blood-related and metabolic disorders. Their primary research and development efforts center on developing unique antithrombotic and anticoagulant compounds that can potentially address unmet medical needs in challenging patient populations.

The company has secured multiple federal grants from the National Heart, Lung, and Blood Institute (NHLBI) to advance specialized medical research projects. These grants include developing a contact activation-targeting antithrombotic agent (AB023/gruticibart) to prevent catheter-related thrombosis in cancer patients, investigating a thrombopoietin conjugate antisense oligonucleotide (AB062) for treating myeloproliferative neoplasms, and exploring antithrombotic approaches for end-stage renal disease patients requiring hemodialysis vascular access. Their research demonstrates a sophisticated approach to targeting specific coagulation factors like Factor XI and Factor XII, with the goal of creating safer anticoagulation strategies that minimize bleeding risks. Each grant represents a Small Business Innovation Research (SBIR) Fast Track project, indicating the company's commitment to translating innovative scientific concepts into potential medical treatments through rigorous clinical research and development processes.

Quick answers

What is Aronora Inc.'s UEI?

Aronora Inc.'s Unique Entity ID (UEI) in SAM.gov is K57JWU3XKX95.

What is Aronora Inc.'s CAGE code?

Aronora Inc.'s CAGE code is 6WCC6.

What is Aronora Inc.'s primary NAICS code?

Aronora Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Aronora Inc. located?

Aronora Inc.'s physical address in SAM.gov is 1818 SW 4th Ave, Portland, OR 97201, USA.

Is Aronora Inc. registered in SAM.gov?

Yes. Aronora Inc.'s SAM.gov registration is active through September 28, 2027.

What is Aronora Inc.'s most recent federal award?

Aronora Inc.'s most recent federal grant award is Contact pathway inhibitor to prevent catheter-related thrombosis - project summary indwelling central venous catheters… (R44HL170881), from National Heart Lung and Blood Institute, on June 15, 2024.

On GovTribe

See Aronora Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors